• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
LBT
Click for more information
5.56% 1.7¢

LBT INNOVATIONS LIMITED - Announcements

Market Cap $23.13M  ! watchlist Created with Sketch. Add to my watchlist

LBT Innovations Limited is a medical technology company. The Company is engaged in... LBT Innovations Limited is a medical technology company. The Company is engaged in researching, developing and commercializing technologies for the healthcare and laboratory supply markets and manufacture and sales of the Automated Plate Assessment System (APAS Independence). Its products include APAS Independence, APAS Analysis Modules, APAS-AMR Analysis Module, and APAS PharmaQ. The APAS Independence is a platform technology that automates culture-plate screening and interpretation. The APAS Analysis Modules are the intelligent image analysis software that works together with the APAS Independence to enable the screening of microbiology culture plates. The APAS-AMR Analysis Module uses artificial intelligence mage analysis platform to read and interpret antimicrobial susceptibility tests (ASTs) for the detection of antimicrobial resistance (AMR). The APAS PharmaQC provides automated imaging, analysis and interpretation of microbiology culture plates used in environmental monitoring.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
LBTPreliminary Final ReportPRICE SENSITIVE21/08/12
LBTAppendix 4C - quarterlyPRICE SENSITIVE24/07/12
LBTAppendix 4C - quarterlyPRICE SENSITIVE26/04/12
LBTLBT Lodges International PatentsPRICE SENSITIVE16/03/12
LBTAppendix 4D Half Year ResultsPRICE SENSITIVE21/02/12
LBTLBT and bioMerieux Agree Minimum RoyaltyPRICE SENSITIVE13/02/12
LBTAppendix 4C - quarterlyPRICE SENSITIVE20/01/12
LBTEarnings GuidancePRICE SENSITIVE20/12/11
LBTAppendix 4C - quarterlyPRICE SENSITIVE18/10/11
LBTPreliminary Final ReportPRICE SENSITIVE12/08/11
LBTAppendix 4C - quarterlyPRICE SENSITIVE27/07/11
LBTEarnings GuidancePRICE SENSITIVE21/04/11
LBTAppendix 4C - quarterlyPRICE SENSITIVE21/04/11
LBTSale of 100th Previ IsolaPRICE SENSITIVE15/04/11
LBTAppendix 4D - Half Yearly ResultsPRICE SENSITIVE18/02/11
LBTAppendix 4C - quarterlyPRICE SENSITIVE20/01/11
LBTEarnings GuidancePRICE SENSITIVE15/12/10
LBTAppendix 4C - quarterlyPRICE SENSITIVE28/10/10
LBTKey US Patent granted for LBTPRICE SENSITIVE28/09/10
LBTPreliminary Final ReportPRICE SENSITIVE17/08/10
LBTAppendix 4C - quarterlyPRICE SENSITIVE28/07/10
LBTFirst PREVI Isola sale in AustraliaPRICE SENSITIVE01/07/10
LBTAppendix 4C - quarterlyPRICE SENSITIVE20/04/10
LBTMilestone Release, LBT Achieves Next Milestone PaymentPRICE SENSITIVE19/04/10
LBTAppendix 4D - Half Yearly ResultsPRICE SENSITIVE17/02/10
LBTLBT Key European Patent GrantedPRICE SENSITIVE02/02/10
LBTAppendix 4C - quarterlyPRICE SENSITIVE21/01/10
LBTAppendix 4C - quarterlyPRICE SENSITIVE21/01/10
LBTProfit ForecastPRICE SENSITIVE18/12/09
LBTChairman's Address to ShareholdersPRICE SENSITIVE20/11/09
LBTAppendix 4C - quarterlyPRICE SENSITIVE15/10/09
LBTPreliminary Final ReportPRICE SENSITIVE18/08/09
LBTAustralian Patent Granted for Key TechnologyPRICE SENSITIVE18/08/09
LBTMarket Update and Earnings GuidancePRICE SENSITIVE11/08/09
LBTAppendix 4C - quarterlyPRICE SENSITIVE31/07/09
LBTAppendix 4C - quarterlyPRICE SENSITIVE29/04/09
LBTHalf Yearly ResultsPRICE SENSITIVE16/02/09
LBTAppendix 4D - Half Yearly ResultsPRICE SENSITIVE16/02/09
LBTAppendix 4C - quarterlyPRICE SENSITIVE29/01/09
LBTPreliminary Final Report
21/08/12PRICE SENSITIVE
LBTAppendix 4C - quarterly
24/07/12PRICE SENSITIVE
LBTAppendix 4C - quarterly
26/04/12PRICE SENSITIVE
LBTLBT Lodges International Patents
16/03/12PRICE SENSITIVE
LBTAppendix 4D Half Year Results
21/02/12PRICE SENSITIVE
LBTLBT and bioMerieux Agree Minimum Royalty
13/02/12PRICE SENSITIVE
LBTAppendix 4C - quarterly
20/01/12PRICE SENSITIVE
LBTEarnings Guidance
20/12/11PRICE SENSITIVE
LBTAppendix 4C - quarterly
18/10/11PRICE SENSITIVE
LBTPreliminary Final Report
12/08/11PRICE SENSITIVE
LBTAppendix 4C - quarterly
27/07/11PRICE SENSITIVE
LBTEarnings Guidance
21/04/11PRICE SENSITIVE
LBTAppendix 4C - quarterly
21/04/11PRICE SENSITIVE
LBTSale of 100th Previ Isola
15/04/11PRICE SENSITIVE
LBTAppendix 4D - Half Yearly Results
18/02/11PRICE SENSITIVE
LBTAppendix 4C - quarterly
20/01/11PRICE SENSITIVE
LBTEarnings Guidance
15/12/10PRICE SENSITIVE
LBTAppendix 4C - quarterly
28/10/10PRICE SENSITIVE
LBTKey US Patent granted for LBT
28/09/10PRICE SENSITIVE
LBTPreliminary Final Report
17/08/10PRICE SENSITIVE
LBTAppendix 4C - quarterly
28/07/10PRICE SENSITIVE
LBTFirst PREVI Isola sale in Australia
01/07/10PRICE SENSITIVE
LBTAppendix 4C - quarterly
20/04/10PRICE SENSITIVE
LBTMilestone Release, LBT Achieves Next Milestone Payment
19/04/10PRICE SENSITIVE
LBTAppendix 4D - Half Yearly Results
17/02/10PRICE SENSITIVE
LBTLBT Key European Patent Granted
02/02/10PRICE SENSITIVE
LBTAppendix 4C - quarterly
21/01/10PRICE SENSITIVE
LBTAppendix 4C - quarterly
21/01/10PRICE SENSITIVE
LBTProfit Forecast
18/12/09PRICE SENSITIVE
LBTChairman's Address to Shareholders
20/11/09PRICE SENSITIVE
LBTAppendix 4C - quarterly
15/10/09PRICE SENSITIVE
LBTPreliminary Final Report
18/08/09PRICE SENSITIVE
LBTAustralian Patent Granted for Key Technology
18/08/09PRICE SENSITIVE
LBTMarket Update and Earnings Guidance
11/08/09PRICE SENSITIVE
LBTAppendix 4C - quarterly
31/07/09PRICE SENSITIVE
LBTAppendix 4C - quarterly
29/04/09PRICE SENSITIVE
LBTHalf Yearly Results
16/02/09PRICE SENSITIVE
LBTAppendix 4D - Half Yearly Results
16/02/09PRICE SENSITIVE
LBTAppendix 4C - quarterly
29/01/09PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
1.7¢ 		Change
-0.001(5.56%) 		Mkt cap ! $23.13M
Open High Low Value Volume
1.8¢ 1.8¢ 1.7¢ $13.20K 747.0K

Buyers (Bids)

No. Vol. Price($)
4 776749 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.8¢ 238095 1
View Market Depth
Last trade - 16.10pm 26/11/2024 (20 minute delay) ?
LBT (ASX) Chart

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia New Zealand’s Reserve Bank has taken a bold step, slashing rates by 50 basis points to 4.25% @ its third cut in just four months. Meanwhile, the Reserve Bank of Australia holds firm at 4.35%, its highest rate in over a decade.This stark policy divergence highlights contrasting glo...
Resolute shares bounce back as second payment made to Mali government to secure workers' release Resolute Mining Ltd has told investors that a second payment has been made to the Mali government following the detention of three employees
HotCopper Highlights: Your most watched stocks for Week 48, 2024 Good afternoon, a happy end of the week, and welcome to HotCopper Highlights – I’m Jonathon Davidson. Let’s get into it.
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor The ASX200 has been really flirting with the 8,500pts mark this week, notching an intraweek ATH of 8,476pts.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.